Compounds > idarubicin
Page last updated: 2024-08-23

idarubicin and rhamnose

idarubicin has been researched along with rhamnose in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blijlevens, NM; de Pauw, BE; Donnelly, JP; M'Rabet, L; van't Land, B1
Blijlevens, NM; de Pauw, BE; Donnelly, JP1

Other Studies

2 other study(ies) available for idarubicin and rhamnose

ArticleYear
Measuring mucosal damage induced by cytotoxic therapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:4

    Topics: 3-O-Methylglucose; Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Gastric Mucosa; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Intestinal Mucosa; Lactulose; Leukemia, Myeloid; Male; Middle Aged; Mouth Mucosa; Myelodysplastic Syndromes; Permeability; Rhamnose; Stomatitis; Transplantation Conditioning; Whole-Body Irradiation; Xylose

2004
Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant.
    Bone marrow transplantation, 2005, Volume: 35, Issue:7

    Topics: Adult; Anthracyclines; Antineoplastic Agents; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Intestinal Mucosa; Lactulose; Male; Middle Aged; Myeloablative Agonists; Permeability; Prospective Studies; Rhamnose; Stomatitis; Transplantation Conditioning

2005